HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/6/C1457    most recent 00165.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Nader, G. A. Articles by Esser, K. A. Search for Related Content PubMed PubMed Citation Articles by Nader, G. A. Articles by Esser, K. A.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

mTOR function in skeletal muscle hypertrophy: increased ribosomal RNA via cell cycle regulators

School of Kinesiology, The University of Illinois at Chicago, Chicago, Illinois

Submitted 7 April 2005 ; accepted in final form 27 July 2005

The purpose of this study was to identify the potential downstream functions associated with mammalian target of rapamycin (mTOR) signaling during myotube hypertrophy. Terminally differentiated myotubes were serum stimulated for 3, 6, 12, 24, and 48 h. This treatment resulted in significant myotube hypertrophy (protein/DNA) and increased RNA content (RNA/DNA) with no changes in DNA content or indices of cell proliferation. During myotube hypertrophy, the increase in RNA content was accompanied by an increase in tumor suppressor protein retinoblastoma (Rb) phosphorylation and a corresponding increase in the availability of the ribosomal DNA transcription factor upstream binding factor (UBF). Serum stimulation also induced an increase in cyclin D1 protein expression in the differentiated myotubes with a concomitant increase in cyclin D1-dependent cyclin-dependent kinase (CDK)-4 activity toward Rb. The increases in myotube hypertrophy and RNA content were blocked by rapamycin treatment, which also prevented the increase in cyclin D1 protein expression, CDK-4 activity, Rb phosphorylation, and the increase in UBF availability. Our findings demonstrate that activation of mTOR is necessary for myotube hypertrophy and suggest that the role of mTOR is in part to modulate cyclin D1-dependent CDK-4 activity in the regulation of Rb and ribosomal RNA synthesis. On the basis of these results, we propose that common molecular mechanisms contribute to the regulation of myotube hypertrophy and growth during the G₁ phase of the cell cycle.

muscle growth; ribosome biogenesis

This article has been cited by other articles:

				J. M. McClung, M. A. Whidden, A. N. Kavazis, D. J. Falk, K. C. DeRuisseau, and S. K. Powers Redox regulation of diaphragm proteolysis during mechanical ventilation Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1608 - R1617. [Abstract] [Full Text] [PDF]

				G. R. Adams, F. Haddad, P. W. Bodell, P. D. Tran, and K. M. Baldwin Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats J Appl Physiol, November 1, 2007; 103(5): 1644 - 1654. [Abstract] [Full Text] [PDF]

				J. J. McCarthy and K. A. Esser Counterpoint: Satellite cell addition is not obligatory for skeletal muscle hypertrophy J Appl Physiol, September 1, 2007; 103(3): 1100 - 1102. [Full Text] [PDF]

				A. A. Hayashi and C. G. Proud The rapid activation of protein synthesis by growth hormone requires signaling through mTOR Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1647 - E1655. [Abstract] [Full Text] [PDF]

				T. Garma, C. Kobayashi, F. Haddad, G. R. Adams, P. W. Bodell, and K. M. Baldwin Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise J Appl Physiol, January 1, 2007; 102(1): 135 - 143. [Abstract] [Full Text] [PDF]

				S. J. Crozier, M. D. Sans, L. Guo, L. G. D'Alecy, and J. A. Williams Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice J. Physiol., June 15, 2006; 573(3): 775 - 786. [Abstract] [Full Text] [PDF]